Researchers have identified 14 novel biomarkers for type 2 diabetes. The biomarkers can serve as basis for developing new methods of treatment and prevention. They can also be used to determine diabetes risk at a very early point in time and enable insight into the complex mechanisms of this disease, which still have not been completely elucidated.